BG108572A - Метод за получаване на есциталопрам - Google Patents

Метод за получаване на есциталопрам Download PDF

Info

Publication number
BG108572A
BG108572A BG108572A BG10857204A BG108572A BG 108572 A BG108572 A BG 108572A BG 108572 A BG108572 A BG 108572A BG 10857204 A BG10857204 A BG 10857204A BG 108572 A BG108572 A BG 108572A
Authority
BG
Bulgaria
Prior art keywords
formula
group
compound
escitalopram
cyano group
Prior art date
Application number
BG108572A
Other languages
Bulgarian (bg)
English (en)
Inventor
Sommer Michael Bech
Ole Nielsen
Hans Petersen
Haleh Ahmadian
Henrik Pedersen
Peter Brosen
Fiona Geiser
James Lee
Geoffrey Cox
Olivier DAPREMONT
Christina Suteu
Sebastian Assenza
Shankar Hariharan
Usha Nair
Original Assignee
H.Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27222518&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG108572(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by H.Lundbeck A/S filed Critical H.Lundbeck A/S
Publication of BG108572A publication Critical patent/BG108572A/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C215/28—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C07C215/30—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings containing hydroxy groups and carbon atoms of six-membered aromatic rings bound to the same carbon atom of the carbon skeleton
    • C07C215/32—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings containing hydroxy groups and carbon atoms of six-membered aromatic rings bound to the same carbon atom of the carbon skeleton containing hydroxy groups and carbon atoms of two six-membered aromatic rings bound to the same carbon atom of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
BG108572A 2001-07-13 2004-02-09 Метод за получаване на есциталопрам BG108572A (bg)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200101101 2001-07-13
DKPA200101851 2001-12-11
DKPA200101852 2001-12-11

Publications (1)

Publication Number Publication Date
BG108572A true BG108572A (bg) 2005-03-31

Family

ID=27222518

Family Applications (1)

Application Number Title Priority Date Filing Date
BG108572A BG108572A (bg) 2001-07-13 2004-02-09 Метод за получаване на есциталопрам

Country Status (29)

Country Link
US (2) US20050065207A1 (es)
EP (1) EP1409472A1 (es)
JP (1) JP2004538276A (es)
KR (4) KR20080108628A (es)
CN (2) CN101265199A (es)
AR (1) AR034759A1 (es)
AU (1) AU2009200448A1 (es)
BG (1) BG108572A (es)
BR (1) BR0210817A (es)
CA (1) CA2451124C (es)
CO (1) CO5550496A2 (es)
EA (1) EA014823B1 (es)
HK (1) HK1069386A1 (es)
HR (1) HRPK20031074B3 (es)
HU (1) HUP0401451A3 (es)
IL (1) IL159183A0 (es)
IS (1) IS7064A (es)
ME (1) MEP2008A (es)
MX (1) MXPA04000205A (es)
MY (1) MY144333A (es)
NO (1) NO328561B1 (es)
PE (1) PE20030253A1 (es)
PL (1) PL366383A1 (es)
RS (1) RS1804A (es)
TW (1) TWI268926B (es)
UA (1) UA84258C2 (es)
UY (1) UY27379A1 (es)
WO (1) WO2003006449A1 (es)
ZA (1) ZA200309471B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI306846B (en) * 2002-08-12 2009-03-01 Lundbeck & Co As H Method for the separation of intermediates which may be used for the preparation of escitalopram
CA2511143C (en) 2002-12-23 2011-06-28 H. Lundbeck A/S Preparation of racemic and/or s- or r-citalopram diols and their use for the preparation racemic and/or s- or r-citalopram
FR2853650B1 (fr) * 2003-04-10 2006-07-07 Merck Sante Sas Procede de dedoublement d'amines utiles pour le traitement de desordres associes au syndrome d'insulino-resistance
ES2228274B1 (es) * 2003-09-24 2006-06-01 Astur Pharma, S.A. Sintesis quimioenzimatica de (+)-citalopram y (-)-citalopram.
TWI339651B (en) * 2004-02-12 2011-04-01 Lundbeck & Co As H Method for the separation of intermediates which may be used for the preparation of escitalopram
US20050196453A1 (en) 2004-03-05 2005-09-08 H. Lundbeck A/S Crystalline composition containing escitalopram
ITMI20040717A1 (it) 2004-04-09 2004-07-09 Adorkem Technology Spa Procedimento chemo-enzimatico per la preparazione dell'escitalopram
JP2006008603A (ja) * 2004-06-25 2006-01-12 Sumitomo Chemical Co Ltd 光学活性シタロプラムの製造方法、その中間体およびその製造方法
US7989645B2 (en) * 2004-08-23 2011-08-02 Sun Pharma Global Fze Process for preparation of citalopram and enantiomers
KR101166280B1 (ko) 2004-08-23 2013-11-27 썬 파마 글로벌 에프제트이 시탈로프램 및 에난티오머의 제조 방법
ITMI20041872A1 (it) 2004-10-01 2005-01-01 Adorkem Technology Spa Processo per la preparazione di citalopram e di scitalopram
WO2006106531A1 (en) * 2005-04-04 2006-10-12 Jubilant Organosys Ltd Process for the preparation of escitalopram or its acid addition salts
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
TWI347942B (en) 2005-06-22 2011-09-01 Lundbeck & Co As H Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
CA2625835A1 (en) 2005-10-14 2007-05-10 Forest Laboratories, Inc. Methods of treating central nervous system disorders with a low dose combination of escitalopram and bupropion
US20090247772A1 (en) * 2005-11-14 2009-10-01 H. Lundbeck A/S Method for the Preparation of Escitalopram
GB0601286D0 (en) 2006-01-23 2006-03-01 Sandoz Ag Asymmetric synthesis
DK1988086T4 (en) 2007-04-23 2015-03-02 Synthon Bv Method of dissolving citalopram via its (S) -riched citalopram tartrate compound
EP2017271A1 (en) 2007-07-06 2009-01-21 Aurobindo Pharma Limited Process for the preparation of escitalopram
FI121570B (fi) 2007-09-11 2011-01-14 Lundbeck & Co As H Menetelmä essitalopraamin valmistamiseksi
US8022232B2 (en) 2007-09-11 2011-09-20 H. Lundbeck A/S Method for manufacture of escitalopram
CN106568863A (zh) * 2016-11-04 2017-04-19 北京万全德众医药生物技术有限公司 一种用高效液相色谱法分离测定草酸艾司西肽普兰中间体光学异构体的方法
CN107941962A (zh) * 2017-12-28 2018-04-20 北京和合医学诊断技术股份有限公司 检测血液中艾司西酞普兰药物含量的液相色谱分析方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) * 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
JP3010816B2 (ja) * 1991-08-22 2000-02-21 ダイセル化学工業株式会社 光学分割における光学異性体と溶媒との回収方法、溶媒の循環使用方法、および光学異性体の再利用方法
US5514818A (en) * 1993-09-17 1996-05-07 Daicel Chemical Industries, Ltd. Resolution of stereoisomers of aliphatic epoxides
US5889180A (en) * 1997-11-10 1999-03-30 Uop Llc Use of small pore silicas as a support for a chiral stationary phase
NL1017415C1 (nl) * 2000-02-24 2001-05-18 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
US6967259B2 (en) * 2001-09-24 2005-11-22 Pharmachem Technologies Limited Process for the preparation of Citalopram intermediate
US6764200B1 (en) * 2003-01-15 2004-07-20 Hsiang Lan Wu Liu Decorative lantern

Also Published As

Publication number Publication date
AR034759A1 (es) 2004-03-17
CN100457746C (zh) 2009-02-04
HUP0401451A3 (en) 2007-05-29
KR20080108628A (ko) 2008-12-15
EA014823B1 (ru) 2011-02-28
US20110065938A1 (en) 2011-03-17
IL159183A0 (en) 2004-06-01
WO2003006449A1 (en) 2003-01-23
HRPK20031074B3 (en) 2009-10-31
CN101265199A (zh) 2008-09-17
HRP20031074A2 (en) 2004-04-30
US20050065207A1 (en) 2005-03-24
KR100956260B1 (ko) 2010-05-07
MY144333A (en) 2011-08-29
CA2451124C (en) 2009-11-24
UA84258C2 (en) 2008-10-10
PE20030253A1 (es) 2003-03-19
UY27379A1 (es) 2003-02-28
BR0210817A (pt) 2004-06-22
HK1069386A1 (en) 2005-05-20
CO5550496A2 (es) 2005-08-31
EA200400177A1 (ru) 2004-06-24
MXPA04000205A (es) 2004-03-18
KR20040030046A (ko) 2004-04-08
ZA200309471B (en) 2004-12-06
AU2009200448A1 (en) 2009-03-05
TWI268926B (en) 2006-12-21
PL366383A1 (en) 2005-01-24
NO328561B1 (no) 2010-03-22
NO20040027L (no) 2004-01-05
CA2451124A1 (en) 2003-01-23
KR20080108629A (ko) 2008-12-15
MEP2008A (xx) 2010-02-10
KR20100036387A (ko) 2010-04-07
EP1409472A1 (en) 2004-04-21
JP2004538276A (ja) 2004-12-24
IS7064A (is) 2003-12-04
HUP0401451A2 (hu) 2004-11-29
RS1804A (en) 2006-12-15
CN1527825A (zh) 2004-09-08

Similar Documents

Publication Publication Date Title
BG108572A (bg) Метод за получаване на есциталопрам
KR101119309B1 (ko) （3，4?디메톡시?바이시클로〔4．2．0〕옥타?1，3，5?트리엔?7?일）니트릴의 거울상이성질체의 분리 방법 및 이바브라딘의 합성에서의 적용
US20050154051A1 (en) Method for the preparation of escitalopram
JP2009523749A (ja) カルボニルの不斉アルキル化
JP2009523749A5 (es)
TW200418750A (en) Method for the separation of intermediates which may be used for the preparation of escitalopram
Ooi et al. Asymmetric Synthesis of α‐Acyl‐γ‐butyrolactones Possessing All‐Carbon Quaternary Stereocenters by Phase‐Transfer‐Catalyzed Alkylation
IL193845A (en) METHOD FOR RESOLUTION AND INSULATION OF ANTIENTOMERS MACITELOPRAM IN THE RATE OR OXYMATIC MIXTURE OF ANANTIMERS
US11319277B2 (en) Process for converting S-enantiomer to its racemic form
KR20050044310A (ko) 치환된 테트라사이클릭 테트라하이드로푸란 유도체의 신규만델레이트 염
AU2002354525A1 (en) Method for the preparation of escitalopram
KR101071293B1 (ko) 광학 활성 2-설포닐옥시-1-헤테로아릴에탄올 유도체의 제조방법 및 이를 이용한 거울상 이성질체적으로 순수한 헤테로아릴-아미노 알코올의 제조방법
EP2125772B1 (en) A process for the preparation of duloxetin and new key intermediates for use therein
JP6182183B2 (ja) デュロキセチン塩基及びデュロキセチン塩酸塩の製造方法
JP2004155756A (ja) 光学活性アルコールの製造方法
JP2001213864A (ja) ラクタムの異性体混合物の異性体分離のための方法ならびにこうして得られた光学対掌体の使用
JP2005255659A (ja) 官能基化された中員環アミン類とその製法